Polyzystische Lebererkrankung 1
Die polyzystische Lebererkrankung vom Typ 1 ist eine autosomal dominante Erkrankung die durch Mutationen im PRKCSH-Gen hervorgerufen wird.
Gliederung
Polyzystische Lebererkrankung
|
|||||
|
LRP5
| ||||
|
Polyzystische Lebererkrankung 1
| ||||
|
|
PRKCSH
| |||
|
|
Polyzystische Lebererkrankung 2
| ||||
|
|
|
|
|
|
Referenzen:
| 1. |
Reynolds DM et. al. (2000) Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. [^] |
| 2. |
Li A et. al. (2003) Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. [^] |
| 3. |
Drenth JP et. al. (2003) Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. [^] |
| 4. |
Sotaniemi EA et. al. (1979) Impairment of drug metabolism in polycystic non-parasitic liver disease. [^] |
| 5. |
Karhunen PJ et. al. (1986) Adult polycystic liver and kidney diseases are separate entities. [^] |
| 6. |
Berrebi G et. al. (1982) Autosomal dominant polycystic liver disease: a second family. [^] |
| 7. |
Luoma PV et. al. (1980) Low high-density lipoprotein and reduced antipyrine metabolism in members of a family with polycystic liver disease. [^] |
